Home › Compare › SCRH vs MRK

SCRH vs MRK: Dividend Comparison 2026

SCRH yields 2000000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCRH wins by $4.879226400974806e+39M in total portfolio value
10 years
SCRH
SCRH
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full SCRH calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — SCRH vs MRK

📍 SCRH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCRHMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCRH + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SCRH pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCRH
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, SCRH beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCRH + MRK for your $10,000?

SCRH: 50%MRK: 50%
100% MRK50/50100% SCRH
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SCRH
No analyst data
Altman Z
-98.1
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCRH buys
0
MRK buys
0
No recent congressional trades found for SCRH or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCRHMRK
Forward yield2000000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.879226400974806e+39M$30.7K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$4.879195005460081e+39M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCRH vs MRK ($10,000, DRIP)

YearSCRH PortfolioSCRH Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,192$351.54+$200.00M → SCRH
2$3,738,731,768,458$3,738,517,757,009.35$12,524$392.70+$3738731.76M → SCRH
3$65,315,062,866,930,490$65,311,062,423,938,240.00$14,015$438.65+$65315062866.92M → SCRH
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$15,682$489.96+$1066400830062625.00M → SCRH
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$17,547$547.23+$16272182796453826560.00M → SCRH
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$19,632$611.16+$2.3205424011366188e+23M → SCRH
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$21,963$682.53+$3.0927990661046884e+27M → SCRH
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$24,571$762.18+$3.8524105697352695e+31M → SCRH
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$27,486$851.08+$4.484688260147987e+35M → SCRH
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$30,745$950.29+$4.879226400974806e+39M → SCRH

SCRH vs MRK: Complete Analysis 2026

SCRH — Stock

Scores Holding Company, Inc., together with its subsidiaries, licenses the Scores trademarks and other intellectual property to gentlemen's nightclubs with adult entertainment in the United States. As of February 15, 2022, it licensed its trademarks to six clubs under the Scores name in Chicago, Illinois; Tampa, Florida; Mooresville, North Carolina; Palm Springs, Florida; Las Vegas, Nevada; and Huntsville, Alabama. Scores Holding Company, Inc. was incorporated in 1981 and is based in New York, New York.

Full SCRH Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this SCRH vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCRH vs SCHDSCRH vs JEPISCRH vs OSCRH vs KOSCRH vs MAINSCRH vs JNJSCRH vs ABBVSCRH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.